Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot/Feasibility Study of Ledipasvir/Sofosbuvir as Treatment for Hepatitis C in Hematopoietic Cell Transplantation (HCT) Recipients.

NCT03279133 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT03279133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03279133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot/Feasibility Study of Ledipasvir/Sofosbuvir as Treatment for Hepatitis C in Hematopoietic Cell Transplantation (HCT) Recipients.
Lead sponsor
Kaiser Permanente
Phase
Phase 4
Overall status
Withdrawn
Start date
September 1, 2017
Completion date
April 29, 2018
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic stem cell transplantation